Feasibility Study is First Phase of €3.4M BioWin Award LIEGE, Belgium, Oct. 25, 2017 /PRNewswire/ — Nexeon MedSystems Inc (OTCBB: NXNN)…
Nexeon Begins Clinical Study with Newly Developed Non-Invasive Vagus Nerve Stimulator
Nexeon MedSystems Goes Public, Receives Innovation Grants
Nexeon shares are trading over the counter as the company moves forward with advanced medical systems. As Nexeon MedSystems Inc.…